Intratumoral xenogeneic tissue-specific cell immunotherapy inhibits tumor growth by increasing antitumor immunity in murine triple negative breast and pancreatic tumor models-Reference-Cited by-同舟云学术

Intratumoral xenogeneic tissue-specific cell immunotherapy inhibits tumor growth by increasing antitumor immunity in murine triple negative breast and pancreatic tumor models

Published:2022-10 Issue: Volume:545 Page:115478
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Huang Chi-Ping,Liu Liang-Chih,Chang Chih-Chun,Wu Chun-Chie,Shyr Chih-Rong

Funder

Ministry of Science and Technology, Taiwan

China Medical University

China Medical University Hospital

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. Breakthrough of the year 2013. Cancer immunotherapy;Couzin-Frankel;Science,2013

2. A guide to cancer immunotherapy: from T cell basic science to clinical practice;Waldman;Nat. Rev. Immunol.,2020

3. The blockade of immune checkpoints in cancer immunotherapy, Nature reviews;Pardoll;Cancer,2012

4. Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting;Herrscher;Curr. Opin. Oncol.,2020

5. Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?;D'Abreo;Nat. Rev. Clin. Oncol.,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer;Clinical Breast Cancer;2024-08

2. Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer;Cancer Cell International;2024-07-10

3. Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies;Frontiers in Immunology;2024-05-13

4. A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance;Cancer Letters;2023-12

5. Immunotherapeutic Agents for Intratumoral Immunotherapy;Vaccines;2023-11-14